Lv1
70 积分 2025-11-29 加入
Therapy-related myeloid neoplasms: when genetics and environment collide
3个月前
已完结
Clinical impact of clonal hematopoiesis in patients with lymphoma undergoing ASCT: a national population-based cohort study
3个月前
已完结
Unanswered questions following reports of secondary malignancies after CAR-T cell therapy
4个月前
已完结
Long-term outcomes following CAR T cell therapy: what we know so far
4个月前
已完结
Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy
4个月前
已完结
Second Primary Cancer After Chimeric Antigen Receptor–T-Cell Therapy
4个月前
已完结
CAR T cell immunotherapy for human cancer
4个月前
已完结
‘Off-the-shelf’ allogeneic CAR T cells: development and challenges
4个月前
已完结
Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy
4个月前
已完结
Targeting epigenetic reprogramming in DLBCL and its interaction with the tumor microenvironment for novel therapeutic approaches
5个月前
已完结
皖公网安备34019202002308
